Formation of lipids, peptides and cytokines

Allergologia et Immunopathologia

Volumn 24, Issue 5, 1996, Pages 211-218

  Monteseirin J ^a,b   Prados, M ^a   Guardia, P ^a   Delgado, J ^a   De La Calle, A ^a   Camacho, M J ^a   Conde, M A ^a   Conde, J ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^b NONE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIMYCIN; CALCIUM; CYTOKINE; ICOSANOID; IONOPHORE; LIPID; LIPOXYGENASE; PROSTAGLANDIN SYNTHASE; THROMBOCYTE ACTIVATING FACTOR;

BIOSYNTHESIS; EOSINOPHIL; HUMAN; INFLAMMATION; METABOLISM; PATHOLOGY; PEPTIDE SYNTHESIS; PHYSIOLOGY; REVIEW;

CALCIMYCIN; CALCIUM; CYTOKINES; EICOSANOIDS; EOSINOPHILS; HUMANS; INFLAMMATION; IONOPHORES; LIPIDS; LIPOXYGENASE; PEPTIDE BIOSYNTHESIS; PLATELET ACTIVATING FACTOR; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;

EID: 0030226380     PISSN: 03010546     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (110)

1. Debbaghi A, Hidi R, Vargaftig BB, Touqui L. Inhibition of phospholipase A2 activity in guinea pig eosinophils by human recombinant 11-1 J Immunol. 1992,149:1374-1380.
2. Barnes P J, Kroegel C, Yukawa T, Dent G, Chung K.F Farmacologia de los eosinófilos. In: Eostnófilos, alergia y asma. Ancora SA Eds. Barcelona 1992;146-159.
3. Lee TC, Leniham DJ, Malone B, Roddy LL, Wasserman S.I Increased biosynthesis of platelet activating factor in activated human eosinophils J Biol Chem. 1984;259:5526-5530
4. Lee TC, Malone B, Wasserman SI. Fitzgerald V, Snyder F. Activities of enzymes than metabolize platelet-activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) in neutrophils and eosinophils from humans and the effect of a calcium ionophore. Biochem Biophys Res Commun. 1982;105:1303-1308
5. Capron M Eosinophils: receptors and mediators in hypersensitivity Clin Exp Allergy. 1989,19(Suppl 1) 3-8.
6. Fukuda T, Gleich GJ Heterogeneity of human eosinophils. J Allergy Clin Immunol 1989;83:369-373.
7. Cromwell O, Wardlaw AJ, Champion A, Moqbel R, Osei D, Kay A B IgG-dependent generation of platelet-activating factor by normal and low density human eosinophils. J Immunol. 1990,145:3862-3868.
8. Ojima-Uchiyama A, Masuzawa Y, Sugiura T, Waku K, Fukuda T, Makino S. Production of platelet-activating factor by human normodense and hypodense eosinophils. Lipids. 1991;26:1200-1203
9. Burke LA, Crea AE, Wilkinson JR, Arm JP, Spur B.W, Lee T.H. Comparison of the generation of platelet-activating factor and leukotriene C4 in human eosinophils stimulated by unopsonized zymosan and by the calcium ionophore A23187:the effects of nedocromil sodium. J Allergy Clin Immunol. 1990,85.26-35.
10. Shikano M, Masuzawa Y, Yazawa K. Effect of Decosahexaenoic Acid on the generation of platelet activating factor by eosinophilic leukemia cells,EOL-1. J Immunol. 1993;150:3525-3533.
11. Triggiani M, Schleimer R.P, Tomioka K, Hubbard W.C, Chilton F H Characterization of platelet activatins factor synthesized by normal and granulocyte macrophage colony stimulating factor primed human eosinophils. Immunology. 1992;77:500-504.
12. Capron M, Prinn L, Ameisen JC, Capron A. Receptores para las inmunoglobulinas en los leucocitos eosinófilos. In : Eosinófilos, alergia y Asma. Ancora S.A. eds. Barcelona 1992:11-20
13. Capron M, Grangette C, Torpier G, Capron A. The second receptor for IgE in eosinophil effector. Chemical Immunol. 1989,47 128-138.
14. Sedgwick JB, Calhoun WJ, Vrtis RF, Bates ME, McAllister PK, Busse WW Comparison of airway and blood eosinophil function after in vivo antigen challenge. J Immunol. 1992, 149 3710-3718.
15. Hubscher T. Role of the eosinophil in the allergic reactions. II Release of prostaglandins from human eosinophilic leukocytes. J Immunol. 1975;114:1389-1393.
16. Weller PF, Lee CW, Foster DW, Corey EJ, Austen KF, Lewis RA. Generation and metabolism of 5 lipoxygenase pathway leukotrienes by human eosinophils: predominant production of leukotriene C4. Proc Natl Acad Sci USA. 1983;80:7626-7630.
17. Verhagen J, Bruijnzeel PLB, Koedam JA, Wassink GA, De Boer M, Terpstra M, Kreukniet J, Veldink GA, Vliegenthart J. Specific leukotriene formation by purified human eosinophils and neutrophils. FEBS Lett. 1984;168.23-28
18. Shak S, Goldstein IM. Leukotriene B4 -hydroxylase in human polymorphonuclear leukocytes partial purification and identification as a cytochrome P-450. J Clin Invest. 1985;76:1218-1228
19. Kroegel C, Matthys H. Platelet-activating factor-induced human eosinophil activation. Generation and release of cyclooxygenase metabolites in human blood eosinophils from asthmatics. Immunology 1993,78:279-285.
20. Bruijnzeel PLB, Verhagen J. Lipid metabolism by eosinophils. In:Eosinophils in asthma Morley J, Colditz I,eds. Academic Press,San Diego, 1989:69-85.
21. Foegh ML, Maddox YT, Ramwell PW. Human peritoneal eosinophils and formation of arachidonate cycloxygenase products. Scand J Immunol. 1986;23:599-603.
22. Parsons WG, Roberts LJ. Transformation of prostaglanclin D2 to isometric prostaglandin F2 compounds by human eosinophils.A potential mast cell-eosinophil interaction. J Immunol. 1988;141.2413-2419
23. Owen WF, Soberman RJ, Yoshimoto T, Sheffer L, Lewis RA, Austen KF. Synthesis and release of leukotriene C4 by human eosinophils. J Immunol. 1987;138: 532-538.
24. Tamura N, Agrawal DK. and Townley RG. Leukotriene C4 production from human eosinophils in vitro: role of eosinophil chemotactic factors on eosinophil activation. J Immunol. 1988;141: 4291-4297.
25. Borgeat P, Fruteau De Laclos B, Rabinovitch H, Picard S, Braquet P, Hebert J, Laviolette M. Eosinophil-rich human polymorphonuclear leukocyte preparations characteristically release leukotriene C4 on ionophore A23187 challenge. J Allergy Clin Immunol. 1984;74:310-315.
26. Henderson WR, Harley JB, Fauci AS. Arachidonic acid metabolism in normal and hypereosinophilic syndrome eosinophils:generation of leukotrienes B4, C4.D4 and 15-lipoxigenase products. Immunology 1984;51:679-686
27. Shaw RJ, Cromwell O, Kay AB Preferential generation of leukotriene C4 by human eosinophils Clin Exp Immunol. 1984;56:716-722.
28. Kajita T, Yui Y, Mita H, Taniguchi N, Saito H, Mishima T Release of leukotriene C4 from human eosinopphils and its relation to the cell density. Int Arch Allergy appl Immunol 1985;78:406-410.
29. Laviolette M, Picard S, Braquet P, Borgeat P Comparison of 5 and 15-lipoxygenase activities in blood and alveolar leukocyte preparations from normal subjects and patients with eosinophiha. Prostaglandins Leukotrienes Med. 1986;23 191-199
30. Bruijnzeel PLB, Kok PT, Hameling ML, Kijne AM, Verhagen J. Exclusive leukotrien C4 synthesis by purified human eosinophils induced by opsonized zymosan. FEBS Lett. 1985,189:350-354
31. Bruynzeel PLB, Verhagen J. The possible role of particular leukotrienes in the allerge-induced late-phase asthmatic reaction. Clin Exp Allergy. 1989,19(Suppl 1):25-32.
32. Woods JW, Evans JF, Ethier D, Scott S, Vickeas PJ, Hearn L, Heibein JA, Charlesson S, Singer II 5-lipoxygenase and 5-lipoxygenase-activating Protein are localized in the nuclear envelope of activated human leukocytes. J Exp Med 1993,178:1935-1946.
33. Kauffman HF, Von Der Belt B, De Monchy JGR, Boelens H, Koe̊ter GH, De Vries K. Leukotriene C4 production by normal-density eosinophils of atopic individuals and other patients with eosinophilia. J Allergy Clin Immunol. 1987;79:611-619.
34. Taniguchi N, Mita H, Saito H, Yui Y, Kajita T, Shida T. Increased generation of leukotriene C4 from eosinophils in asthmatic patients. Allergy. 1985;40:571-573.
35. Hodges MK, Weller PF, Gerard NP, Ackerman SJ, Drazen JM. Heterogeneity of leukotriene C4 production by eosinophils from asthmatic and from normal subjects Am Rev Respir Dis. 1988;138:799-804.
36. Kloprogge I, Leeuw A, Monchy J, Kauffman HF. Hypodense eosinophilic granulocytes in normal individuals and patients with asthma:generation of hypodense cell populations in vitro. J Allergy Clin Immunol. 1989;83:393-400.
37. Rothenberg ME, Owen WF Jr, Silberstein DS, Soberman RJ, Austen KF, Stevens RL. Eosinophil cocultured with endothelial cells have increased survival and functional properties. Science. 1987;237:645-647
38. Owen WF, Petersen J Jr, Austen KF. Eosinophils altered phenotypically and primed by culture with granulocyte/macrophage colony-stimulating factor and 3T3 fibroblasts generate leukotriene C4 in response to FMLP. J Clin invest. 1991,87:1958-1963.
39. Takafuji S, Bischoff SC, De Weck AL, Dahinden CA. IL-3 and IL-5 prime normal human eosinophils to produce leukotriene C4 in response to soluble agonists. J Immunol. 1991;147: 3855-3861.
40. Roubin R, Elsas P.P, Fiers W, Dessein A.J. Recombinant human tumor necrosis factor(rTNF) enhances leukotriene biosynthesis in neutrophils and eosincphils stimulated with the Ca++ ionophore A23187. Clin Exp Immunol. 1987;70:484-490.
41. Fitzharris P, Moqbel R, Thorne K.J, Richardson B.A, Hartnell A, Cromwell O, Butterworth A.E, Kay A.B The effects of eosinophil activating factor on IgG-dependent sulphidopeptide leukotriene generation by human eosinophils. Clin Exp Immunol. 1986,66:673-680.
42. Dessein AJ, Lee TH, Elsas P, Ravalese J, Silberstein D, David JR, Austen KF, Lewis RA. Enhancement by monokines of leukotriene generation by human eosinophils and neutrophils stimulated with calcium ionophore A23187. J Immunol. 1986,136:3829-3838.
43. Elsas PX, Elsas MI, Dessein AJ. Eosinophil cytotoxicity enhancing factor: purification, characterization and immunocytochemical localization on the monocyte surface. Eur J Immunol 1990;20:1143-1151.
44. Mahauthaman R, Howell CJ, Spur BW, Youlten LJ, Clark TJ, Lessof MH, Lee TH. The generation and cellular distribution of leukotriene C4 in human eosinophils stimulated by unopsonized zymosan and glucan particles J Allergy Clin Immunol. 1988;81:697-705.
45. Moqbel R, Macdonald AJ, Cromwell O, Kay AB. Release of leukotriene C4 (LTC4) from human eosinophils following adherence to IgE and IgG coated schistosomula of schistosoma mansoni. Immunology. 1990;69:435-442.
46. Cromwell O, Moqbel R, Fitzharris P, Kurlak L, Harvey C, Walsh GM, Shaw RJ, Kay AB. Leukotriene C4 generation from human eosinophils stimulated with IgG-Aspergillus fumigatus antigen immune complexe J Allergy Clin Immunol 1988;82:535-544.
47. Thien F.C.K, Hallsworth M.P, Soh C, Lee T.H. Effects of exogenous Eicosapentanoic Acid on generation of leukotriene C4 and leukotriene C5 by calcium ionophore-activated human eosinophils in vitro. J Immunol. 1993;150.3546-3552
48. Nadel J.A, Conrad D.J, Veki I.F, Schuster A, Sigal E. Immunocytochemical localization of arachidonate 15-lipoxygenase in erythrocytes,leukocytes and airway cells. J Clin Invets. 1991;87:1139-1145.
49. Shannon V.R, Chanez P, Bousquet J, Holtzman M.J. Histochemical evidence for induction of arachidonate 15-lipoxygenase in airway disease. Am Rev Respir Dis. 1993;147:1024-1028
50. Turk J, Maas RI, Brash AR, Roberts LJ, Oates JA. Arachidonic acid 15 lipoxygenase products from human eosinophils. J Biol Chem. 1982;257.7068-7076.
51. Maas R.L, Turk J, Oates JA, Brash AR Formation of a novel dihydroxy acid from arachidonic acid by lipoxygenase-catalyzed double oxygenation in rat mononuclear cells and human leukocytes. J Biol Chem. 1982;257:7056-7067.
52. Maron Z, Shelhamer JH, Sun F, Kaliner M. Human airway monohydroxyeicosatetranoic acid generation and mucus release J Clin Invest 1983;72:122-127
53. Kirsch CM, Sigal E, Djokiic TD, Graf PD, Nadel JA. An in vivo chemotaxis assay in the dog trachea:evidence for chemotactic activity of 8,15-diHETE. J Appl Physiol. 1988;64:1792-1795.
54. Shak S, Perez D, Goldstein IM. A novel dioxy-generation product of arachidonic acid possess potent chemotactic activity for human polymorphonuclear leukocytes. J Biol Chem. 1983;258:14948-14953.
55. Ramstedt U, Serhan CM, Lundberg U, Wigzell H, Samuelsson B. Inhibition of human natural killer cell activity by (14R,14S)-15-Dihydroxy-5Z,8Z,10E,12E-eicosatetranoic acid. Proc Natl Acad Sci USA. 1984;81:6914-6918.
56. Serhan CN, Nicolaou KC, Webber SE, Veale CA, Dahlem SE, Puustinen TJ, Samuelsson B, Lipoxin A.Stereochemistry and biosynthesis. J Biol Chem. 1986;261.16340-16345.
57. Dahlen SE, Franzen L, Raud J, Serhan CN, Westlund P, Wikstrom E, Bjorck T, Matsuda H, Webber SE, Veale CA, Puustinen TJ, Haeggstrom J, Nikolaou KC, Samuelsson B. In:Lipoxins:chemistry,biosynthesis and biological activities Wong P.Y.C,Serhan CN,eds Plenum New York,1988:107-130.
58. Serhan C.N, Fahlstadius P, Dahlen SE, Hamberg M, Samuelsson B. Biosynthesis and biological activities of lipoxins Ad Prost Tromb Leuk Res Vol 15 Hoyaishi O,Yamamoto S, eds. Raven Press, New York. 1985:163-166.
59. Rokach J, Adams J, Fitzsimmons BJ, Girard Y, Leblanc Y, Evans JF Chemical and enzimatic synthesis of Lipoxin A:stereochemical assignment of natural Lipoxin A and its possible biosynthesis. Ad Prost Tromb Leuk Res vol 15 Hoyaishi O,Yamamoto S,eds. Raven Press,New York,1985:309-312
60. Fiore S, Romano M, Reardon EM, Serhan CN. Induction of functional Lipoxin A4 receptors in HL-60 cells. Blood. 1993;81:3395-3403.
61. Serhan CN, Hirsch U, Palmblad J, Samuelsson B. Formation of lipoxin A by granulocytes from eosinophilic donors FEBS lett. 1987;217:242-246.
62. Steinhilber D, Roth HJ. New series of lipoxins isolated from human eosinophils FEBS Lett 1989;255.143-148.
63. Lee TH, Crea AEG, Gant V, Spur BW, Marron BE, Nicolaou KC, Reardon E, Brezinski M, Serhan CN. Identification of Lipoxin A4 and its relationship to the sulfidopeptide leukotrienes C4,D4, and E4 in the bronchoalveolar lavage fluids obtained from patients with selected pulmonary diseases. Am Rev Respir Dis. 1990;141:1453-1458
64. Christie PE, Spur BW, Lee TH. The effects of Lipoxin A4 on airway responses in asthmatic subjects. Am Rev Respir Dis. 1992;145:1281-1285.
65. Hedqvist P, Raud J, Palmertz U, Haeggstrom J, Nikolaou KC, Dahlen SE. Lipoxin A4 inhibits leukotriene B4-induced inflammation in the hamster cheek pouch. Acta Physiol Scand. 1989,137571-572.
66. Lee TH, Horton CE, Kyan AU, Haskard D, Crea AE, Spur BW. Lipoxin A4 and Lipoxin B4 inhibit chemotactic responses of human neutrophils stimulated by leukotriene B4 and N-formyl-L-methionyl-L-Leucyl-L-phenylalanine. Clin Sci 1989;77:195-203
67. Colgan SP, Serhan CN, Parkos CA, Delp-Archer C, Madara JL Lipoxin A4 modulates transmigration on human neutrophils acros intestinal epithelial monolayers J Clin Invest. 1993;92:75-82.
68. Grandordy BH, Lacroix H, Mavoungou E, Krilis S, Crea AE, Spur BW, Lee TH. Lipoxin A4 inhibits phosphoinositide hydrolisis in human neutrophils. Biochem Biophys Res Commun. 1990;167:1022-1029.
69. Soyombo O, Spur BW, Lee TH. Effects of Lipoxin A4 on chemotaxis and degranulation of human eosinophils stimulated by platelet-activating factor and N-formyl-L-methionyl-L-leucyl-L-phenylalanine. Allergy. 1994,49:230-234
70. Ramstedt U, Serhan CN, Nikolaou KC, Webber SE, Wigzell H, Samuelsson B. Lipoxin A-induced inhibition of natural killer citoxicity:studies on stereospecificity of inhibition and mode of action. J Immunol. 1987;138:266-270.
71. Ahakbari J, Sreedharan SP, Turck CW, Goetzl EJ Selective localization of vasoactive intestinal peptide and substance P in human eosinophils. Biochem Biophys Res Commun. 1987;148:1440-1445.
72. Weinstock JV, Blum AM. Tachykinin production in granulomas of murine schistosomiasis mansoni J Immunol. 1989;142:3256-3261.
73. Weinstock JV, Blum AM. Detection of vasoactive intestinal and localization of its mRNA within granulosmas of murine schistosomiasis. Cell Immunol. 1990;125:291-300
74. Weinstock JV, Blum AM. Release of Substance P by granuloma eosinophils in response to secretagogues in murine schistosomiasis mansoni Cell Immunol. 1990;125:380-385.
75. Weinstock JV, Blum A, Walder J, Walder R. Eosinophils from granulomas in murine schistosomiasis mansoni produce Substance P. J Immunol 1988;141:961-966
76. Kurosawa M, Ishizuka T. Inhibitory effects of vasoactive intestinal peptide on superoxide anion formation by N-Formyl-Leucyl-Phenylalanine-activated inflammatory cells in vitro. Int Arch Allergy Immunol. 1993;100:28-34.
77. Del Pozo V, De Andrés B, Martín E, Cardaba B, Fernández JC, Gallardo S, Tramon P, Layva-Cobián F, Palomino P, Lahoz C Eosinophil as antigen-presenting cell : activation of T cell clones and T cell htbridoma by eosinophils after antigen processing Eur J Immunol. 1992;22: 1919-1925.
78. Truong MJ, Gruart V, Capron A, Capron M, Tourvieille B. Cloning and expression of a cDNA enconding a non-classical MHC class I antigen (HLA-E) in eosinophils from hypereosinophilic patients. J Immumol 1992;148: 627-632
79. Lahoz C, Lauzurica P, Maruri N, Galocha B, Gurbindo C, Hernández D, García R. Nuevos aspectos patogénicos de loseosinófilos en las reacciones alérgicas. Rev Esp Alergol Inmunol Clin 1987;5.401-409.
80. Lahoz C, Del Pozo B, De Andrés V, Martin E, Cardaba B, Fernández JC, Gallardo S, Tramón P. Eosinófilos en la respuesta inmunológica. Rev Esp Allergol Inmunol Clin. 1991;6(Suppl 3):60-61.
81. Hansel TT, De Vries JM, Carballido JM, Braun RK, Carballido-Perrig N, Rihs S, Blaser K, Walker C. Induction and function of eosinophil intercellular adhesion molecule-1 and HLA-DR. J Immunol. 1992,149:2130-2136.
82. Beninati W, Derdak S, Dixons PF, Grider DJ, Strollo DC, Hensley RE, Lucey DR. Pulmonary eosinophils express HLA-DR in chronic eosinophilic pneumonia. J Allergy Clin Immunol. 1993;92:442-449
83. Weller PF, Rand TH, Barrett T, Elovic A, Wong DT, Finberg RW. Accesory cell function of human eosinophils :HLA-DR dependent,MHC-restricted antigen presentation and interleukin-1 formation J Immunol. 1993;150:2554-2562.
84. Corrigan CJ, Kay AB. T cells and eosinophils in the pathogenesis of asthma Immunol Today. 1992;13 501-507
85. Wong DTW, Weiler PF, Galli SJ, Rand TH, Elovic A, Chiang T, Chou MY, Gallagher GT, Matossian K, McBride J, Todd R. Human eosinophils express transforming growth factor. J Exp Med. 1990;172:673-681
86. Todd R, Chou MY, Matossian K, Gallagher GF, Donoff RB, Wong DT. Cellular sources of transforming growth factor-alpha in human oral cancer. J Dent Res 1991;70:917-923
87. Emery S, Elovic A, Wong D, Weller PF, Galli SJ. Expression of transforming growth factor-alfa(TGF-) mRNA by human eosinophils in diverse pathological processes. FASEB J. 1991,5:A1695.
88. Elovic A, Wong D, Weller P, Matossian K, Galli S. Expression of transforming growth factors-a and b1 messenger RNA and product by eosinophils in nasal polyps. J Allergy Clin Immunol. 1994,93:864-869
89. Madtes DK, Raines EW, Sakariassen KS, Assoian RK, Sporn MB, Bell GI, Ross R. Induction of transforming growth factor- in activated human alveolar macrophages. Cell. 1988;53:285-293.
90. Rappolee DA, Mark D, Brenda MJ, Werb Z Wound macrophages express TGF- and other growth factors in vivo.analysis by mRNA phenotyping. Science 1988;241:708-712.
91. Lyons RM, Moses HL Transforming growth factors and the regulation of cell proliferation. Eur J Biochem 1990;187:467-473
92. Massagué J Transforming growth factor. J Biol Chem. 1990;265:21393-21396
93. Roche WR, Beasley R, Williams J H, Holgate ST. Subepithelial fibrosis in the bronchi of asthmatics. Lancet. 1989;1:520-524.
94. Brewster CEP, Howarth PH, Djukanovic R, Wilson J, Holgate ST, Roche WR. Myofibroblasts and subepithelial fibrosis in bronchial asthma. Am J Resp Cell Mol Biol. 1990;3:507-511.
95. Wong DT, Elovic A, Matossian K, Nagura N, McBride J, Chou MY, Gordon JR, Rand TH, Galli SJ, Weller PF. Eosinophils from patients with blood eosinophilia express transforming growth factor beta 1 Blood. 1991;78: 2702-2707.
96. Ohno I, Lea RG, Flanders KC, Clark DA, Banwatt D, Dolovich J, Denburg J. Eosinophils in cronically inflamed human uper airway tissues espress Transforming Growth Factor 1 gene (TGF-1). J Clin Invest 1992;89:1662-1668.
97. Elovic A, Wong D, Weller P, Matossian K, Galli S. Expression of transforming growth factors-a and b1 messenger RNA and product by eosinophils in nasal polyps. J Allergy Clin Immunol. 1994;93:864-869.
98. Del Pozo V, De Andrés V, Martin E, Maruri N, Zubeldia JM, Palomino P, Lahoz C Murine eosinophils and 1L-1 : IL-1 mRNA detection by in situ hybridization. J Immunol. 1990;144:3117-3122.
99. Kita H, Ohnishi T, Okubo Y, Weilar D, Abrams JS, Gleich GH. Granulocyte/Macrophage Colony Stimulating Factor and Interleukin-3 release from human peripheral blood eosinophils and neutrophils. J Exp Med. 1991;174.745-748.
100. Dent LA, Strath M, Mellor AL, Sanderson CJ. Eosinophilia in transgenic mice expressing interleukin 5 receptor. J Exp Med. 1990;172:1425-1431
101. Broide DH, Paine MM, Firestein GS. Eosinophils express Interleukin-5 and Granulocyte Macrophage Colony Stimulating Factor mRNA at sites at allergic inflammation in asthmatics. J Clin Invest. 1992;90:1414-1424
102. Desreumauz P, Janin A, Colombel JF, Prin L, Plumas J, Emiliee D, Torpier G, Capron A, Capron M. Interleukin-5 messenger RNA expression by eosinophils in the intestinal mucosa of patients with coeliac disease. J Exp Med. 1992;175:293-296
103. Moqbel R, Hamid Q, Ying S, Barkans J, Harnell A, Tsicopoulos A, Wardlaw AJ, Kay AB. Expression of mRNA and immunoreactivity for the granulocyte/macrophage colony-stimulating factor in activated human eosinophils. J Exp Med. 1991; 174:749-752.
104. Ohno I, Lea R, Finotto S, Marshall J, Denburg J, Dolovic J, Gauldie J, Jordana M. Granulocyte/Macrophage Colony Stimulating Factor (GM-CSF) gene expression by eosinophils in nasal polyposis. Am Rev Respir Cell Mol Biol 1991;5:505-510.
105. Girgis-Gabardo A, Kanai N, Denburg J, Hargreave F, Jordana M, Dolovich J. Immunocytochemical detection of granulocyte-macrophage colony-stimulating factor and eosinophil cationic protein in sputum cells J Allergy Clin Immunol. 1994;93:945-947.
106. Chihara J, Plumas J, Gruart V, Tavernier J, Prin L, Capron A, Capron M. Characterization of a receptor for interleukin r on human eosinophils variable expression and induction by Granulocyte/macrophage Colony-Stimulating Factor. J Exp Med. 1990;172:1347-1351.
107. Braun RK, Franchini M, Erard F, Rihs S, De Vries IJ, Blaser K, Hansel TT, Walker C. Human peripheral blood eosinophils produce and release Interleukin-8 on stimulation with calcium ionophore. Eur J Immunol 1993;23:2673-2684.
108. Melani C, Mattia GF, Silvani A, Care A, Rivoltini L, Parmiani G, Colombo MP. Interleukin-6 expression in human neutrophil and eosinophil peripheral blood granulocytes. Blood. 1993;81.2744-2749.
109. Costa JJ, Matossian K, Beil WJ, Wong DTW, Gordon JR, Dvorak AM, Weller PF, Galli SJ. Human eosinophils can express the cytokines TNF- and MIP-1 J Clin Invest 1993;23.956-960.
110. Slungaard GM, Vercellotti GM, Walker G, Nelson RD, Jacob HS. Tumor Necrosis Factor-/Cachectin stimulates eosinophil oxidant production and toxtcity towards human endothelium. J Exp Med 1990;171:2025-2041.